Answers are grounded in this paper and cite their sources.
To assess the effectiveness of a switch to faricimab in individuals affected by DME and previously treated with aflibercept.
No takes yet. Share an insight, caveat, or question.
Pichi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: